z-logo
open-access-imgOpen Access
Persister Development by Borrelia burgdorferi Populations In Vitro
Author(s) -
John Caskey,
Monica E. Embers
Publication year - 2015
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00883-15
Subject(s) - borrelia burgdorferi , doxycycline , microbiology and biotechnology , multidrug tolerance , lyme disease , antibiotics , biology , borrelia , bacterial growth , in vitro , population , spirochaetaceae , bacteria , immunology , medicine , biofilm , biochemistry , genetics , environmental health , antibody
Doxycycline is an antibiotic commonly used to treat Lyme disease and other bacterial infections. The MIC and minimum bactericidal concentration (MBC) forBorrelia burgdorferi have been investigated by different groups but were experimentally established in this study as a function of input cell density. We demonstrated thatB. burgdorferi treated in the stationary phase has a higher probability of regrowth following removal of antibiotic. In addition, we determined experimentally and mathematically that the spirochetes which persist posttreatment do not have a longer lag phase but exhibit a lower growth rate than untreated spirochetes. Finally, we found that treating the spirochetes by pulse-dosing did not eliminate growth or reduce the persister populationin vitro . From these data, we propose thatB. burgdorferi persister development is stochastic and driven by slowed growth.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom